title: Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching.
abstract: Preimplantation HLA matching has recently emerged as a tool for couples desiring to conceive a potential donor progeny for transplantation in a sibling with a life-threatening disorder. In this paper we describe a strategy optimized for preimplantation genetic diagnosis (PGD) of haemoglobinopathies combined with HLA matching. This procedure involves a minisequencing-based genotyping of HLA regions A, B, C and DRB combined with mutation analysis of the gene regions involved by mutation. Analysis of at least eight polymorphic short tandem repeat (STR) markers scattered through the HLA complex has also been included to detect potential contamination and crossing-over occurrences between HLA genes. The above assay can also be used for preimplantation HLA matching as a primary indication. The strategy was clinically applied for HLA matching in 17 cycles (14 for beta-thalassaemia, one for Wiscott-Aldrich syndrome and two for leukaemia). A reliable HLA genotype was achieved in 255/266 (95.9%) of the blastomeres. In total, 22 (14.8%) embryos were obtained that were HLA-matched with the affected siblings, 14 (9.4%) of which were unaffected and transferred back to the patients. Four clinical pregnancies were obtained, three of which (one twin, two singletons) are ongoing and were confirmed as healthy and HLA-identical with the affected children. Minisequencing-based HLA typing combined with HLA STR haplotyping has been shown to be a reliable strategy for preimplantation HLA matching. The major advantage of this approach is that the validation of a single assay can be done once and then used for the majority of the patients, reducing notably time needed for preclinical set-up of each case.
authors.affiliation: EmbryoGen (Centre for Preimplantation Genetic Diagnosis), Rome, Italy. fiorentino@embryogen.it
authors.forename: F
authors.initials: F
authors.lastname: Fiorentino
authors.forename: A
authors.initials: A
authors.lastname: Biricik
authors.forename: H
authors.initials: H
authors.lastname: Karadayi
authors.forename: H
authors.initials: H
authors.lastname: Berkil
authors.forename: G
authors.initials: G
authors.lastname: Karlikaya
authors.forename: S
authors.initials: S
authors.lastname: Sertyel
authors.forename: D
authors.initials: D
authors.lastname: Podini
authors.forename: M
authors.initials: M
authors.lastname: Baldi
authors.forename: M C
authors.initials: MC
authors.lastname: Magli
authors.forename: L
authors.initials: L
authors.lastname: Gianaroli
authors.forename: S
authors.initials: S
authors.lastname: Kahraman
mesh_terms: D001755:Blastocyst / Q000502:physiology; D004252:DNA Mutational Analysis; D004624:Embryo Transfer; D005260:Female; D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D006680:HLA Antigens / Q000235:genetics*; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D008285:Major Histocompatibility Complex; D018895:Microsatellite Repeats; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011256:Pregnancy Outcome; D019836:Preimplantation Diagnosis / Q000379:methods*
chemical_list: D006680:HLA Antigens